Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift E Cameroni, JE Bowen, LE Rosen, C Saliba, SK Zepeda, K Culap, ... Nature 602 (7898), 664-670, 2022 | 1207 | 2022 |
An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies LA VanBlargan, JM Errico, PJ Halfmann, SJ Zost, JE Crowe Jr, LA Purcell, ... Nature medicine 28 (3), 490-495, 2022 | 776 | 2022 |
Subcutaneous REGEN-COV antibody combination to prevent Covid-19 MP O’Brien, E Forleo-Neto, BJ Musser, F Isa, KC Chan, N Sarkar, KJ Bar, ... New England Journal of Medicine 385 (13), 1184-1195, 2021 | 513 | 2021 |
Tackling COVID-19 with neutralizing monoclonal antibodies D Corti, LA Purcell, G Snell, D Veesler Cell 184 (12), 3086-3108, 2021 | 427 | 2021 |
The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites M Yu, TRS Kumar, LJ Nkrumah, A Coppi, S Retzlaff, CD Li, BJ Kelly, ... Cell host & microbe 4 (6), 567-578, 2008 | 341 | 2008 |
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies FA Lempp, LB Soriaga, M Montiel-Ruiz, F Benigni, J Noack, YJ Park, ... Nature 598 (7880), 342-347, 2021 | 286 | 2021 |
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains RE Chen, ES Winkler, JB Case, ID Aziati, TL Bricker, A Joshi, TL Darling, ... Nature 596 (7870), 103-108, 2021 | 234 | 2021 |
The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2 AL Cathcart, C Havenar-Daughton, FA Lempp, D Ma, MA Schmid, ... biorxiv, 2021.03. 09.434607, 2021 | 216 | 2021 |
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages YJ Park, D Pinto, AC Walls, Z Liu, A De Marco, F Benigni, F Zatta, ... Science 378 (6620), 619-627, 2022 | 199 | 2022 |
Dupilumab does not affect correlates of vaccine-induced immunity: a randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis A Blauvelt, EL Simpson, SK Tyring, LA Purcell, B Shumel, CD Petro, ... Journal of the American Academy of Dermatology 80 (1), 158-167. e1, 2019 | 150 | 2019 |
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains JB Case, S Mackin, JM Errico, Z Chong, EA Madden, B Whitener, ... Nature communications 13 (1), 3824, 2022 | 140 | 2022 |
Identification of a Mutant PfCRT-Mediated Chloroquine Tolerance Phenotype in Plasmodium falciparum SG Valderramos, JC Valderramos, L Musset, LA Purcell, ... PLoS pathogens 6 (5), e1000887, 2010 | 136 | 2010 |
Adenylyl Cyclase α and cAMP Signaling Mediate Plasmodium Sporozoite Apical Regulated Exocytosis and Hepatocyte Infection T Ono, L Cabrita-Santos, R Leitao, E Bettiol, LA Purcell, O Diaz-Pulido, ... PLoS pathogens 4 (2), e1000008, 2008 | 132 | 2008 |
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies JS Low, J Jerak, MA Tortorici, M McCallum, D Pinto, A Cassotta, ... Science 377 (6607), 735-742, 2022 | 126 | 2022 |
Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters R da Silva Antunes, M Babor, C Carpenter, N Khalil, M Cortese, ... The Journal of clinical investigation 128 (9), 3853-3865, 2018 | 126 | 2018 |
Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 113 | 2022 |
Neutralization, effector function and immune imprinting of Omicron variants A Addetia, L Piccoli, JB Case, YJ Park, M Beltramello, B Guarino, H Dang, ... Nature 621 (7979), 592-601, 2023 | 103 | 2023 |
Accelerating antiviral drug discovery: lessons from COVID-19 A von Delft, MD Hall, AD Kwong, LA Purcell, KS Saikatendu, U Schmitz, ... Nature Reviews Drug Discovery 22 (7), 585-603, 2023 | 100 | 2023 |
Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria SJ Higgins, LA Purcell, KL Silver, V Tran, V Crowley, M Hawkes, ... Science translational medicine 8 (358), 358ra128-358ra128, 2016 | 90 | 2016 |
Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge LA Purcell, KA Wong, SK Yanow, M Lee, TW Spithill, A Rodriguez Vaccine 26 (38), 4880-4884, 2008 | 72 | 2008 |